0000899243-22-026881.txt : 20220727 0000899243-22-026881.hdr.sgml : 20220727 20220727183020 ACCESSION NUMBER: 0000899243-22-026881 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220727 FILED AS OF DATE: 20220727 DATE AS OF CHANGE: 20220727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Guerrero Ramiro CENTRAL INDEX KEY: 0001913253 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 221112249 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-07-27 0 0001878313 MAIA Biotechnology, Inc. MAIA 0001913253 Guerrero Ramiro 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 0 0 Common Stock 259382 D Stock Options 1.80 2030-11-14 Common Stock 18000 D Stock Options 10.00 2031-11-14 Common Stock 18000 D Warrants 6.00 Common Stock 3579 D Mr. Guerrero beneficially owns 259,382 shares of common stock. Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 12 equal monthly installments beginning on December 15, 2020. Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 12 equal monthly installments beginning on November 15, 2021. Each Warrant became exercisable on the date of issuance of June 29, 2021, and expires on the earliest to occur of: (a) June 28, 2028; or (b) immediately prior to the closing of any change of control of the issuer. /s/ Ramiro Guerrero 2022-07-27